168 related articles for article (PubMed ID: 32050939)
1. Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA).
Patrikidou A; Chaigneau L; Isambert N; Kitikidou K; Shanley R; Ray-Coquard I; Valentin T; Malivoir B; Laigre M; Bay JO; Moureau-Zabotto L; Bompas E; Piperno-Neumann S; Penel N; Alcindor T; Guillemet C; Duffaud F; Hügli A; Le Pechoux C; Dhermain F; Blay JY; Sperduto PW; Le Cesne A
BMC Cancer; 2020 Feb; 20(1):117. PubMed ID: 32050939
[TBL] [Abstract][Full Text] [Related]
2. Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO).
Chaigneau L; Patrikidou A; Ray-Coquard I; Valentin T; Linassier C; Bay JO; Moureau Zabotto L; Bompas E; Piperno-Neumann S; Penel N; Alcindor T; Laigre M; Guillemet C; Salas S; Hugli A; Domont J; Sunyach MP; Lecesne A; Blay JY; Nerich V; Isambert N
Oncologist; 2018 Aug; 23(8):948-955. PubMed ID: 29934413
[TBL] [Abstract][Full Text] [Related]
3. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.
Sperduto PW; Kased N; Roberge D; Xu Z; Shanley R; Luo X; Sneed PK; Chao ST; Weil RJ; Suh J; Bhatt A; Jensen AW; Brown PD; Shih HA; Kirkpatrick J; Gaspar LE; Fiveash JB; Chiang V; Knisely JP; Sperduto CM; Lin N; Mehta M
J Clin Oncol; 2012 Feb; 30(4):419-25. PubMed ID: 22203767
[TBL] [Abstract][Full Text] [Related]
4. Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases.
Subbiah IM; Lei X; Weinberg JS; Sulman EP; Chavez-MacGregor M; Tripathy D; Gupta R; Varma A; Chouhan J; Guevarra RP; Valero V; Gilbert MR; Gonzalez-Angulo AM
J Clin Oncol; 2015 Jul; 33(20):2239-45. PubMed ID: 25987700
[TBL] [Abstract][Full Text] [Related]
5. Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool.
Sperduto PW; Deegan BJ; Li J; Jethwa KR; Brown PD; Lockney N; Beal K; Rana NG; Attia A; Tseng CL; Sahgal A; Shanley R; Sperduto WA; Lou E; Zahra A; Buatti JM; Yu JB; Chiang V; Molitoris JK; Masucci L; Roberge D; Shi DD; Shih HA; Olson A; Kirkpatrick JP; Braunstein S; Sneed P; Mehta MP
Neuro Oncol; 2018 Nov; 20(12):1652-1660. PubMed ID: 30418657
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.
Sperduto PW; Chao ST; Sneed PK; Luo X; Suh J; Roberge D; Bhatt A; Jensen AW; Brown PD; Shih H; Kirkpatrick J; Schwer A; Gaspar LE; Fiveash JB; Chiang V; Knisely J; Sperduto CM; Mehta M
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):655-61. PubMed ID: 19942357
[TBL] [Abstract][Full Text] [Related]
7. Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery.
Kano H; Morales-Restrepo A; Iyer A; Weiner GM; Mousavi SH; Kirkwood JM; Tarhini AA; Flickinger JC; Lunsford LD
J Neurosurg; 2018 Jan; 128(1):14-22. PubMed ID: 28106495
[TBL] [Abstract][Full Text] [Related]
8. Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome.
Griguolo G; Dieci MV; Giarratano T; Giorgi CA; Orvieto E; Ghiotto C; Berti F; Della Puppa A; Falci C; Mioranza E; Tasca G; Milite N; Miglietta F; Scienza R; Conte P; Guarneri V
J Neurooncol; 2017 Jan; 131(2):369-376. PubMed ID: 27853958
[TBL] [Abstract][Full Text] [Related]
9. Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).
Sperduto PW; Jiang W; Brown PD; Braunstein S; Sneed P; Wattson DA; Shih HA; Bangdiwala A; Shanley R; Lockney NA; Beal K; Lou E; Amatruda T; Sperduto WA; Kirkpatrick JP; Yeh N; Gaspar LE; Molitoris JK; Masucci L; Roberge D; Yu J; Chiang V; Mehta M
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):812-816. PubMed ID: 29063850
[TBL] [Abstract][Full Text] [Related]
10. Surgical outcome and graded prognostic assessment of patients with brain metastasis from adult sarcoma: multi-institutional retrospective study in Japan.
Deguchi S; Nakasu Y; Sakaida T; Akimoto J; Tanahashi K; Natsume A; Takahashi M; Okuda T; Asakura H; Mitsuya K; Hayashi N; Narita Y
Int J Clin Oncol; 2020 Nov; 25(11):1995-2005. PubMed ID: 32648133
[TBL] [Abstract][Full Text] [Related]
11. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
[TBL] [Abstract][Full Text] [Related]
12. External Validation of a Prognostic Score for Patients with Brain Metastases: Extended Diagnosis-Specific Graded Prognostic Assessment.
Nieder C; Hess S; Lewitzki V
Oncol Res Treat; 2020; 43(5):221-227. PubMed ID: 32213772
[TBL] [Abstract][Full Text] [Related]
13. A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment.
Sperduto CM; Watanabe Y; Mullan J; Hood T; Dyste G; Watts C; Bender GP; Sperduto P
J Neurosurg; 2008 Dec; 109 Suppl():87-9. PubMed ID: 19123893
[TBL] [Abstract][Full Text] [Related]
14. Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient.
Sperduto PW; Mesko S; Li J; Cagney D; Aizer A; Lin NU; Nesbit E; Kruser TJ; Chan J; Braunstein S; Lee J; Kirkpatrick JP; Breen W; Brown PD; Shi D; Shih HA; Soliman H; Sahgal A; Shanley R; Sperduto WA; Lou E; Everett A; Boggs DH; Masucci L; Roberge D; Remick J; Plichta K; Buatti JM; Jain S; Gaspar LE; Wu CC; Wang TJC; Bryant J; Chuong M; An Y; Chiang V; Nakano T; Aoyama H; Mehta MP
J Clin Oncol; 2020 Nov; 38(32):3773-3784. PubMed ID: 32931399
[TBL] [Abstract][Full Text] [Related]
15. Cumulative Intracranial Tumor Volume (CITV) Enhances the Prognostic Value of the Lung-Specific Graded Prognostic Assessment (GPA) Model.
Marcus LP; Marshall D; Hirshman BR; McCutcheon BA; Gonda DD; Koiso T; Hattangadi-Gluth JA; Carter BS; Yamamoto M; Chen CC
Neurosurgery; 2016 Aug; 79(2):246-52. PubMed ID: 26579964
[TBL] [Abstract][Full Text] [Related]
16. Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today.
Sperduto PW; Mesko S; Li J; Cagney D; Aizer A; Lin NU; Nesbit E; Kruser TJ; Chan J; Braunstein S; Lee J; Kirkpatrick JP; Breen W; Brown PD; Shi D; Shih HA; Soliman H; Sahgal A; Shanley R; Sperduto W; Lou E; Everett A; Boggs DH; Masucci L; Roberge D; Remick J; Plichta K; Buatti JM; Jain S; Gaspar LE; Wu CC; Wang TJC; Bryant J; Chuong M; Yu J; Chiang V; Nakano T; Aoyama H; Mehta MP
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):334-343. PubMed ID: 32084525
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC.
Woody NM; Greer MD; Reddy CA; Videtic GMM; Chao ST; Murphy ES; Suh JH; Angelov L; Barnett GH; Vogelbaum MA; Stephans KL
Clin Lung Cancer; 2018 Jan; 19(1):e141-e147. PubMed ID: 28739316
[TBL] [Abstract][Full Text] [Related]
18. Development and adaptations of the Graded Prognostic Assessment (GPA) scale: a systematic review.
Ribeiro LM; Bomtempo FF; Rocha RB; Telles JPM; Neto EB; Figueiredo EG
Clin Exp Metastasis; 2023 Dec; 40(6):445-463. PubMed ID: 37819546
[TBL] [Abstract][Full Text] [Related]
19. Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study.
Villà S; Weber DC; Moretones C; Mañes A; Combescure C; Jové J; Puyalto P; Cuadras P; Bruna J; Verger E; Balañà C; Graus F
Radiat Oncol; 2011 Mar; 6():23. PubMed ID: 21366924
[TBL] [Abstract][Full Text] [Related]
20. Validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: extra-cranial disease progression is an independent risk factor.
Zhuang Q; Wong RX; Lian WX; Li YQ; Wong FY
Ann Palliat Med; 2019 Sep; 8(4):390-400. PubMed ID: 30943738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
